blood pressure

September 19, 2019

All-in-one pill helps reduce blood pressure, cholesterol

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.

By Craig Boerner
September 5, 2019

How salt increases blood pressure

Vanderbilt researchers have discovered that a protein called SGK1 in immune cells is activated by sodium, leading to the development of salt-sensitive hypertension.

By Leigh MacMillan
July 18, 2019

Madhur receives Presidential Early Career Award

Meena Madhur, MD, PhD, has received a Presidential Early Career Award for Scientists and Engineers.

By Leigh MacMillan
A training program for a new tool used by cardiologists and anesthesiologists to help criticall ill patients
May 9, 2019

Line placement better with ultrasound

Using ultrasound to place arterial lines reduces the need for surgical access and improves arterial line location, Vanderbilt researchers have found.

By Paul Govern
March 28, 2019

Drug interaction causes hypotension

A muscle relaxing-drug and inhibitors of the metabolic enzyme CYP1A2 interact to cause severely low blood pressure and should not be co-prescribed, Vanderbilt investigators caution.

By Leigh MacMillan
December 31, 2018

Hundreds of new blood pressure gene variations discovered

By Bill Snyder
November 13, 2017

Salt, inflammation and hypertension

Vanderbilt researchers have identified a pathway that links excess sodium, inflammation and hypertension.
By Leigh MacMillan
October 6, 2016

Madhur lands NIH New Innovator Award

Meena Madhur, M.D., Ph.D., assistant professor of Medicine, has received an NIH New Innovator Award, which is designed to support exceptionally creative, early-career investigators who propose innovative, high-impact projects.
By Leigh MacMillan
December 10, 2015

Hypertension-related visits to emergency rooms on rise in U.S.

The number and percentage of patients treated at emergency departments for hypertension are on the rise across the United States, according to a Vanderbilt study published recently in The American Journal of Cardiology.
By Andrew Wiese
September 17, 2015

Study shows lower systolic BP targets reduce death risk

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.
By Kathy Whitney
April 30, 2015

Team tracks how kidney responds to blood pressure meds

Changes in the kidney can limit the blood pressure-lowering effects of thiazide diuretics, a new study reports.
By Leigh MacMillan
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.
By Leigh MacMillan
June 6, 2013

Study tracks skin salt’s role in blood pressure control

Clinical pharmacologist Jens Titze, M.D., and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.
By Leigh MacMillan